High Incidence of Kaposi's Sarcoma in Iceland and the Faroe Islands
Author Information
Author(s): H Hjalgrim, H Tulinius, J Dalberg, S Hardarson, M Frisch, M Melbye
Primary Institution: Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark
Hypothesis
What factors contribute to the high incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands?
Conclusion
The study found surprisingly high incidence rates of classical Kaposi's sarcoma in both Iceland and the Faroe Islands.
Supporting Evidence
- The incidence rates of Kaposi's sarcoma in Iceland and the Faroe Islands were among the highest ever reported in Caucasian populations.
- In Iceland, the world standardized incidence rate was 0.4 per 100,000 person-years for men and 0.3 for women.
- In the Faroe Islands, the rates were 0.6 for men and 0.5 for women.
- None of the patients were immigrants, suggesting local factors may contribute to the high incidence.
Takeaway
This study looked at how many people got a rare skin cancer called Kaposi's sarcoma in Iceland and the Faroe Islands, and found that a lot more people had it there than in other places.
Methodology
The study involved reviewing cancer registry data and original histological specimens to confirm diagnoses of Kaposi's sarcoma.
Potential Biases
There is a risk of bias due to the small sample size and the specific populations studied.
Limitations
The study is based on a relatively small number of cases, which limits the conclusions that can be drawn.
Participant Demographics
The study included 19 cases in Iceland (9 men, 10 women) and 7 cases in the Faroe Islands (4 men, 3 women).
Want to read the original?
Access the complete publication on the publisher's website